ICD-10: Q50.32

Ovarian streak

Clinical Information

Inclusion Terms

  • 46, XX with streak gonads

Additional Information

Description

ICD-10 code Q50.32 refers to "Ovarian streak," a condition characterized by the presence of fibrous tissue in the ovaries, which can lead to a range of reproductive and hormonal issues. Below is a detailed clinical description and relevant information regarding this condition.

Clinical Description of Ovarian Streak

Definition

Ovarian streak is a condition where the normal ovarian tissue is replaced by fibrous or streak-like tissue. This can occur due to various developmental anomalies, often associated with conditions such as Turner syndrome, where one of the X chromosomes is missing or partially missing, leading to underdeveloped ovaries.

Etiology

The primary cause of ovarian streak is often linked to genetic abnormalities, particularly in females with Turner syndrome. In these cases, the absence of functional ovarian tissue results in a lack of estrogen production, which can lead to secondary sexual characteristics not developing properly during puberty. Other potential causes may include congenital malformations or hormonal imbalances.

Clinical Features

Patients with ovarian streak may present with:
- Primary Amenorrhea: The absence of menstruation by age 15, which is common in individuals with Turner syndrome.
- Infertility: Due to the lack of functional ovarian tissue, individuals may experience difficulties in conceiving.
- Short Stature: Often associated with Turner syndrome, which can be a clue in diagnosing ovarian streak.
- Other Physical Anomalies: Such as webbed neck, broad chest, and low-set ears, which are characteristic of Turner syndrome.

Diagnosis

Diagnosis of ovarian streak typically involves:
- Clinical Evaluation: A thorough medical history and physical examination to assess for signs of Turner syndrome or other related conditions.
- Imaging Studies: Ultrasound may be used to visualize the ovaries and assess for the presence of streak tissue.
- Karyotyping: Genetic testing to confirm the presence of Turner syndrome or other chromosomal abnormalities.

Management

Management of ovarian streak primarily focuses on addressing the symptoms and associated conditions:
- Hormone Replacement Therapy (HRT): To induce secondary sexual characteristics and manage symptoms of estrogen deficiency.
- Fertility Treatments: Options may be limited due to the absence of functional ovaries, but assisted reproductive technologies may be explored in some cases.
- Psychosocial Support: Counseling may be beneficial for individuals coping with the implications of infertility and hormonal imbalances.

Conclusion

Ovarian streak, represented by ICD-10 code Q50.32, is a significant condition often associated with Turner syndrome and characterized by the replacement of ovarian tissue with fibrous streaks. Understanding its clinical features, diagnostic approaches, and management options is crucial for healthcare providers in delivering comprehensive care to affected individuals. Early diagnosis and appropriate management can help mitigate some of the challenges associated with this condition, particularly regarding reproductive health and hormonal balance.

Clinical Information

Overview of ICD-10 Code Q50.32: Ovarian Streak

ICD-10 code Q50.32 refers to "Ovarian streak," a condition characterized by the presence of streak gonads, which are underdeveloped or absent ovarian tissue. This condition is often associated with disorders of sexual development and can have significant implications for reproductive health and hormonal balance.

Clinical Presentation

The clinical presentation of ovarian streak can vary widely among individuals, but it typically includes the following characteristics:

  • Absence of Ovarian Function: Patients may present with primary amenorrhea (the absence of menstruation) due to the lack of functional ovarian tissue.
  • Delayed Puberty: Individuals may experience delayed secondary sexual characteristics, such as breast development and pubic hair growth, due to insufficient estrogen production.
  • Short Stature: Some patients may exhibit short stature, which can be a result of growth hormone deficiencies or other endocrine issues associated with the condition.
  • Infertility: Many individuals with ovarian streak may face challenges with fertility due to the absence of functional ovaries.

Signs and Symptoms

The signs and symptoms associated with ovarian streak can include:

  • Physical Examination Findings: Upon examination, there may be signs of underdeveloped external genitalia or ambiguous genitalia, depending on the degree of gonadal dysgenesis.
  • Hormonal Imbalances: Laboratory tests may reveal low levels of estrogen and other sex hormones, which can lead to symptoms such as hot flashes or other menopausal-like symptoms in older patients.
  • Associated Anomalies: Patients may have other congenital anomalies, particularly those related to the reproductive system, such as Müllerian agenesis or other developmental disorders.

Patient Characteristics

Patients diagnosed with ovarian streak often share certain characteristics:

  • Genetic Factors: Many individuals with ovarian streak have underlying genetic conditions, such as Turner syndrome, which is characterized by the complete or partial absence of one X chromosome.
  • Age of Diagnosis: The condition is often diagnosed in adolescence when patients present with delayed puberty or primary amenorrhea.
  • Psychosocial Impact: The diagnosis can have significant psychosocial implications, including issues related to body image, self-esteem, and reproductive health.

Conclusion

Ovarian streak, represented by ICD-10 code Q50.32, is a complex condition that requires careful clinical evaluation and management. Understanding the clinical presentation, signs, symptoms, and patient characteristics is crucial for healthcare providers to offer appropriate care and support. Early diagnosis and intervention can help address the physical and emotional challenges faced by individuals with this condition, ultimately improving their quality of life and reproductive health outcomes.

Approximate Synonyms

The ICD-10 code Q50.32 refers specifically to "Ovarian streak," which is classified under congenital malformations of the ovaries and fallopian tubes. Understanding alternative names and related terms for this condition can enhance clarity in medical documentation and communication. Below are some alternative names and related terms associated with Q50.32.

Alternative Names for Ovarian Streak

  1. Streak Ovary: This term is often used interchangeably with ovarian streak and refers to the underdevelopment or absence of ovarian tissue.
  2. Ovarian Streak Syndrome: This broader term may encompass various clinical presentations associated with the absence or dysfunction of ovarian tissue.
  3. Streak Gonads: This term can refer to the presence of streak-like structures in the gonads, which may be indicative of conditions like Turner syndrome.
  1. Congenital Ovarian Malformations: This term encompasses a range of developmental anomalies affecting the ovaries, including ovarian streak.
  2. Turner Syndrome: A genetic condition that often features streak ovaries as a characteristic finding, particularly in females with a missing or incomplete X chromosome.
  3. Hypoplastic Ovaries: This term describes underdeveloped ovaries, which can be a feature of ovarian streak.
  4. Gonadal Dysgenesis: A broader term that includes various forms of abnormal development of the gonads, including streak ovaries.

Clinical Context

Ovarian streak is often identified in the context of genetic conditions, particularly in females with Turner syndrome, where the absence of functional ovarian tissue can lead to various clinical manifestations, including infertility and hormonal imbalances. Understanding these terms is crucial for accurate diagnosis, treatment planning, and coding in medical records.

In summary, while Q50.32 specifically denotes "Ovarian streak," it is associated with several alternative names and related terms that reflect its clinical significance and implications in congenital malformations of the reproductive system.

Diagnostic Criteria

The ICD-10 code Q50.32 refers to "Ovarian streak," which is classified under congenital malformations of the genital organs. Diagnosing this condition involves a combination of clinical evaluation, imaging studies, and genetic testing. Below are the key criteria and methods used for diagnosis:

Clinical Evaluation

  1. Patient History: A thorough medical history is essential. This includes any family history of congenital anomalies, hormonal imbalances, or developmental disorders. The presence of symptoms such as delayed puberty or primary amenorrhea in females may prompt further investigation.

  2. Physical Examination: A physical examination may reveal signs consistent with ovarian streak, such as underdeveloped secondary sexual characteristics or other anomalies related to the reproductive system.

Imaging Studies

  1. Ultrasound: Pelvic ultrasound is a primary diagnostic tool. It can help visualize the ovaries and assess their size and structure. In cases of ovarian streak, the ultrasound may show absent or rudimentary ovarian tissue, which is indicative of the condition[1][2].

  2. MRI: Magnetic Resonance Imaging (MRI) may be used for a more detailed assessment of the pelvic anatomy, especially if there are associated anomalies or if the ultrasound findings are inconclusive.

Genetic Testing

  1. Karyotyping: Genetic testing, including karyotyping, is often performed to identify chromosomal abnormalities. Ovarian streak is commonly associated with Turner syndrome (45,X), where there is a complete or partial absence of one X chromosome. Identifying such chromosomal patterns can confirm the diagnosis[3][4].

  2. Molecular Genetic Testing: In some cases, more specific genetic tests may be conducted to identify mutations or deletions that could be responsible for the condition.

Additional Considerations

  • Hormonal Assessment: Hormonal evaluations may be conducted to assess levels of estrogen and other hormones, which can provide insight into the functional status of the ovaries and the overall endocrine system.

  • Associated Anomalies: It is important to evaluate for other congenital anomalies that may accompany ovarian streak, such as renal or skeletal abnormalities, which can be part of broader syndromic presentations.

Conclusion

The diagnosis of ovarian streak (ICD-10 code Q50.32) is multifaceted, involving clinical assessment, imaging, and genetic testing. Early diagnosis is crucial for managing associated conditions and planning appropriate interventions, particularly in cases where reproductive health may be affected. If you suspect ovarian streak or related conditions, consulting a healthcare provider specializing in genetics or reproductive endocrinology is advisable for comprehensive evaluation and management.


References

  1. ICD-10 Coding Manual List of all Reportable Congenital Malformations.
  2. Billing and Coding: Nonobstetric Pelvic Ultrasound (A56671).
  3. ICD-10-CM Diagnosis Code Q50.32 - Ovarian streak - ICD List.
  4. Congenital Malformations, Deformations and Chromosomal Abnormalities.

Treatment Guidelines

Ovarian streak, classified under ICD-10 code Q50.32, refers to a condition characterized by the presence of fibrous tissue in the ovaries, often associated with Turner syndrome or other developmental anomalies. The management of ovarian streak typically involves a multidisciplinary approach, focusing on the underlying causes, associated symptoms, and the patient's reproductive goals. Below is a detailed overview of standard treatment approaches for this condition.

Understanding Ovarian Streak

Definition and Causes

Ovarian streak is often seen in individuals with Turner syndrome, a genetic disorder resulting from the complete or partial absence of one X chromosome. This condition can lead to various reproductive and developmental issues, including the presence of streak ovaries, which are non-functional and lack the typical ovarian structure. Other causes may include congenital adrenal hyperplasia or other genetic syndromes that affect ovarian development[1].

Symptoms

Patients with ovarian streak may experience:
- Primary amenorrhea (absence of menstruation)
- Delayed puberty
- Infertility
- Hormonal imbalances leading to secondary sexual characteristics not developing properly[1].

Standard Treatment Approaches

1. Hormonal Therapy

Hormonal therapy is often the first line of treatment for individuals with ovarian streak, particularly to address hormonal deficiencies and promote secondary sexual characteristics. This may include:
- Estrogen Replacement Therapy: Administered to induce secondary sexual characteristics and regulate menstrual cycles. This is crucial for patients who have not undergone puberty due to ovarian dysfunction[2].
- Progesterone Therapy: Often combined with estrogen to ensure proper endometrial development and to induce withdrawal bleeding, mimicking a natural menstrual cycle[2].

2. Fertility Treatment

For those desiring pregnancy, fertility treatments may be necessary, as ovarian streak typically results in infertility due to the absence of functional ovarian tissue. Options include:
- Oocyte Donation: Since the ovaries may not produce viable eggs, using donor eggs is a common approach. This involves in vitro fertilization (IVF) where the donor's eggs are fertilized and implanted into the uterus of the patient[3].
- Surrogacy: In cases where the uterus is functional but the ovaries are not, surrogacy may be considered, allowing the patient to have a biological connection to the child through the use of donor eggs[3].

3. Psychological Support

Given the emotional and psychological impact of infertility and hormonal imbalances, psychological support is an essential component of treatment. Counseling and support groups can help patients cope with the challenges associated with ovarian streak and its implications for fertility and body image[4].

4. Monitoring and Management of Associated Conditions

Patients with ovarian streak, particularly those with Turner syndrome, may have other associated health issues, such as cardiovascular problems or renal anomalies. Regular monitoring and management of these conditions are crucial to ensure overall health and well-being[5].

Conclusion

The management of ovarian streak (ICD-10 code Q50.32) is multifaceted, focusing on hormonal therapy, fertility options, psychological support, and monitoring of associated health conditions. Each treatment plan should be tailored to the individual’s specific needs and reproductive goals, ideally involving a team of healthcare professionals, including endocrinologists, gynecologists, and mental health specialists. As research continues to evolve, new treatment modalities may emerge, offering hope and improved outcomes for those affected by this condition.

References

  1. ICD-10 International statistical classification of diseases.
  2. Infertility Testing and Treatment.
  3. Quality and coverage of the NSW Register of Congenital.
  4. BMJ Open is committed to open peer review.
  5. Georgia Department of Public Health Birth Defects Registry.

Related Information

Description

  • Fibrous tissue replaces normal ovarian tissue
  • Genetic abnormalities lead to ovarian streak
  • Turner syndrome often linked to ovarian streak
  • Primary amenorrhea is common symptom
  • Infertility due to lack of functional ovaries
  • Short stature and other physical anomalies
  • Hormone replacement therapy for estrogen deficiency
  • Fertility treatments limited by absent ovaries

Clinical Information

  • Absence of ovarian function
  • Delayed puberty
  • Short stature
  • Infertility issues
  • Physical examination findings
  • Hormonal imbalances present
  • Associated anomalies common

Approximate Synonyms

  • Streak Ovary
  • Ovarian Streak Syndrome
  • Streak Gonads
  • Congenital Ovarian Malformations
  • Turner Syndrome
  • Hypoplastic Ovaries
  • Gonadal Dysgenesis

Diagnostic Criteria

  • Thorough medical history is essential
  • Family history of congenital anomalies is noted
  • Presence of delayed puberty or primary amenorrhea prompts investigation
  • Physical examination reveals underdeveloped secondary sexual characteristics
  • Pelvic ultrasound shows absent or rudimentary ovarian tissue
  • MRI provides detailed assessment of pelvic anatomy
  • Karyotyping identifies chromosomal abnormalities such as Turner syndrome
  • Molecular genetic testing for mutations or deletions is conducted
  • Hormonal evaluations assess estrogen and other hormone levels

Treatment Guidelines

Related Diseases

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.